AI/ML
HealthTech

Iterative Health

Accelerating clinical research with AI

Cambridge· 12 rolesNYC· 8 rolesNYC HQ· 5 roles

CORE INFO

$264M
Total Funding
Series C
Round
2017
Founded
51-200
Team Size
Cambridge, Massachusetts, USA
Headquarters

Iterative Health is a healthcare technology company that leverages artificial intelligence to enhance clinical research, particularly in gastroenterology, hepatology, obesity, and cardiology. Their solutions are designed to improve the efficiency of clinical trials, benefiting pharmaceutical and biotech companies.

  • Iterative Health recently closed a $77 million Series C funding round led by Intrepid Growth Partners and GV (Google Ventures), with participation from EDBI and existing investors.businesswire.com
  • The company has established partnerships with over 40 pharmaceutical, biotech, medical device, and contract research organizations, operating a global network of more than 100 research sites.businesswire.com
  • Iterative Health's AI-driven tools have achieved 2x faster site activation and 3x higher patient enrollment rates, significantly reducing clinical trial startup timelines.businesswire.com

WHY WE WOULD WORK AT ITERATIVE HEALTH

Transform Patient Care

Join a mission-driven team focused on accelerating clinical research to deliver life-changing therapies to patients faster, particularly in critical areas like gastroenterology and cardiology.

Innovative Technology

Work with cutting-edge AI-driven tools like SKOUT, which optimize clinical trials by analyzing endoscopic images and clinical data for conditions such as inflammatory bowel disease.

Collaborative Culture

Be part of a dynamic team that values growth, responsibility, impact, and teamwork, fostering an environment where every member elevates one another.

Competitive Compensation

Benefit from a robust funding history, including a recent $77 million Series C round, ensuring strong financial backing and competitive salaries.

Proven Impact

Contribute to a company that has achieved 2x faster site activation and 3x higher patient enrollment rates, making a tangible difference in clinical trial efficiency.

Global Reach

Engage with a global network of over 100 research sites across North America, Europe, India, and Australia, expanding your professional horizons and impact.

MARKET AND TRACTION

TOTAL ADDRESSABLE MARKET

  • Iterative Health focuses on enhancing clinical research in gastroenterology, hepatology, obesity, and cardiology.

  • The integration of AI in clinical trials positions the company to tap into the growing demand for innovative therapies in these critical healthcare areas.
  • KEY METRICS

    ✦ KEY METRIC
  • Iterative Health has raised a total of $264 million across multiple funding rounds, with the most recent being a $77 million Series C round in April 2026.

  • The company operates a global network of over 100 research sites across North America, Europe, India, and Australia, achieving 2x faster site activation and 3x higher patient enrollment rates.
  • GROWTH TACTICS

  • Iterative Health has established partnerships with over 40 pharmaceutical, biotech, medical device, and contract research organizations to expand its reach and capabilities.

  • The company collaborates with leading provider networks such as GI Alliance and US Heart & Vascular to enhance access to clinical trials within community-based practices.
  • COMPETITIVE ADVANTAGE

  • The flagship product, SKOUT, utilizes AI-driven precision medicine tools to optimize clinical trials, particularly for conditions like inflammatory bowel disease and colorectal cancer.

  • Iterative Health's deep clinical trial expertise combined with advanced AI technology allows for improved efficiency and effectiveness in clinical research.
  • MARKET POSITION

  • Founded in 2017 and headquartered in Cambridge, Massachusetts, Iterative Health has quickly established itself as a leader in healthcare technology focused on clinical research.

  • The company's mission to accelerate clinical research aligns with the increasing need for faster delivery of life-changing therapies to patients, positioning it favorably in the healthcare market.
  • PRODUCT AND TECH

    SKOUT Precision Medicine

    SKOUT is Iterative Health's flagship product that utilizes AI-driven precision medicine tools to analyze endoscopic images and clinical data, optimizing clinical trials for conditions such as inflammatory bowel disease and colorectal cancer.

    AI-Driven Clinical Trials

    The company integrates artificial intelligence into clinical research processes, enhancing the efficiency and effectiveness of trials, which accelerates the delivery of innovative therapies to patients.

    Global Research Network

    Iterative Health operates a global network of over 100 research sites across North America, Europe, India, and Australia, facilitating diverse clinical trials and improving patient access to cutting-edge therapies.

    Partnership Ecosystem

    With partnerships established with over 40 pharmaceutical, biotech, medical device, and contract research organizations, Iterative Health leverages collaborative expertise to enhance clinical trial outcomes.

    Clinical Trial Optimization

    The company focuses on optimizing clinical trial performance, achieving faster site activation and higher patient enrollment rates, which significantly reduces startup timelines and enhances research efficiency.

    COMPANY CULTURE

    Values

  • Growth: Embracing challenges and learning from experiences

  • Responsibility: Acting like owners and maintaining high standards

  • Impact: Focusing on meaningful work and continuous improvement

  • Team: Collaborating to achieve more together
  • Operating Principles

  • Innovation: Leveraging AI to enhance clinical research

  • Efficiency: Streamlining clinical trials for faster results

  • Collaboration: Partnering with over 40 organizations to expand capabilities
  • Benefits

  • Competitive salary and equity options

  • Comprehensive health benefits including medical, dental, and vision

  • Opportunities for professional development and growth
  • Learning & Growth

  • Continuous learning through training and workshops

  • Encouragement of cross-functional collaboration for skill enhancement

  • Support for attending industry conferences and events
  • Team Cadence

  • Regular team meetings to align on goals and progress

  • Open communication channels for feedback and ideas

  • Monthly all-hands meetings to celebrate achievements and share updates
  • COMPENSATION SNAPSHOT

    D
    Comp score vs cohort
    vs. Biotech/Pharma · Series C · US
    Based on publicly available compensation ranges from job postings; exact compensation may vary.
    Operationsn = 7
    $90K$130Kmedian $110K
    New York
    US-only in v1 · only categories with n > 2 shown · in-person / hybrid / remote treated separately where n ≥ 3

    HIRING SIGNAL

    54
    Open roles on their careers page
    Snapshot via live ATS poll
    Net new roles in the last 90 days
    Available once weekly history accrues
    90-Day VelocityV2 · BACKFILL
    Trend builds weekly as historical rows accrue
    By Function
    Breakdown of open roles
    Data · 5
    Other · 32
    GTM · 3
    Design · 2
    G&A · 6
    Product · 1
    Operations · 3
    Engineering · 2
    Top Locations
    Where hiring is concentrated
    Remote-eligible postings counted separately
    Cambridge, Massachusetts, United States, New York, New York, United States
    8
    NYC HQ
    4
    Tucson, AZ
    3
    NYC, BOS or Dallas
    3
    Poland
    2
    Mumbai, India
    2
    Southlake, TX
    2
    NYC, Boston or Dallas
    2
    SourcesGreenhouseLeverAshbyWorkableSmartRecruitersRipplingRecruiteeFallback · Wellfound, YC Work-at-a-Startup, careers-page scrape

    KEY COMPANY ANNOUNCEMENTS

    Filter
    5 announcements · ranked by importance
    Apr 1, 2026FUNDINGIterative Health Closes $77 Million Series C to Accelerate the Future of Clinical Researchbusinesswire.com
    Apr 1, 2026FUNDINGIterative Health Stock Price, Funding, Valuation, Revenue & Financial Statementscbinsights.com
    Jan 1, 2022FUNDINGIterative Health — Company Profile & Key Signals · TexAutexau.com
    Feb 1, 2026EXEC HIREIterative Health Appoints Nadege Gunn, MD, as Chief Medical Officer, Hepatology and Obesity - Iterative Healthiterative.health
    Sep 1, 2025EXEC HIREIterative Health Appoints Bill Kayser as President and Chief Financial Officer - Iterative Healthiterative.health